Market Value2,444,691,159
Total Holdings69
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RVMD / Revolution Medicines, Inc.
JAZZ / Jazz Pharmaceuticals plc
NLTX / Neoleukin Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
HOOK / HOOKIPA Pharma Inc.
PEN / Penumbra, Inc.
CUTR / Cutera, Inc.
XENE / Xenon Pharmaceuticals Inc.
SYK / Stryker Corporation
STXS / Stereotaxis, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
IONS / Ionis Pharmaceuticals, Inc.
AKRO / Akero Therapeutics, Inc.
ANNX / Annexon, Inc.
BVS / Bioventus Inc.
/ ONCOLOGY INSTITUTE INC/THE
ARGX / argenx SE - Depositary Receipt (Common Stock)
TKNO / Alpha Teknova, Inc.
ZYME / Zymeworks Inc.
STTK / Shattuck Labs, Inc.
IVVD / Invivyd, Inc.
OSH / Oak Street Health Inc
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
ONEM / 1life Healthcare Inc
CTSO / Cytosorbents Corporation
TCRR / Tcr2 Therapeutics Inc
LSAQ / LifeSci Acquisition II Corp
SKIN / The Beauty Health Company
PRTA / Prothena Corporation plc
HUM / Humana Inc.
SONX / Sonendo, Inc.
MDVL / MedAvail Holdings, Inc.
ISEE / IVERIC bio Inc
ALLK / Allakos Inc.
ZYME / Zymeworks Inc.
CNC / Centene Corporation
ADCT / ADC Therapeutics SA
LVTX / LAVA Therapeutics N.V.
VERV / Verve Therapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
KRYS / Krystal Biotech, Inc.
SRRK / Scholar Rock Holding Corporation
ALXO / ALX Oncology Holdings Inc.
FOLD / Amicus Therapeutics, Inc.
RGNX / REGENXBIO Inc.
TRDA / Entrada Therapeutics, Inc.
SLGC / Standard BioTools Inc.
IMGN / ImmunoGen, Inc.
STVN / Stevanato Group S.p.A.
NVTA / Invitae Corporation
ELV / Elevance Health, Inc.
CABA / Cabaletta Bio, Inc.
XERS / Xeris Biopharma Holdings, Inc.
IMVT / Immunovant, Inc.
BEAM / Beam Therapeutics Inc.
NUVB / Nuvation Bio Inc.
LIVN / LivaNova PLC
ALVR / AlloVir, Inc.
NRIX / Nurix Therapeutics, Inc.
ABSI / Absci Corporation
FATE / Fate Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
BCEL / Atreca, Inc.
ATRA / Atara Biotherapeutics, Inc.
VTYX / Ventyx Biosciences, Inc.
CLDX / Celldex Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
PRME / Prime Medicine, Inc.
GRTSQ / Gritstone bio, Inc.
REPL / Replimune Group, Inc.
AUGX / Augmedix, Inc.
RAPT / RAPT Therapeutics, Inc.